New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration)

被引:56
作者
Alexander, Bryce [1 ]
Milden, Julia [1 ]
Hazim, Bachar [1 ]
Haseeb, Sohaib [1 ]
Bayes-Genis, Antoni [2 ]
Elosua, Roberto [3 ,4 ,5 ]
Martinez-Selles, Manuel [6 ]
Yeung, Cynthia [1 ]
Hopman, Wilma [1 ]
Bayes de Luna, Antoni [7 ,8 ]
Baranchuk, Adrian [1 ]
机构
[1] Queens Univ, Div Cardiol, Kingston, ON, Canada
[2] Generalitat Catalunya, Barcelona, Spain
[3] Inst Hosp del Mar Invest Med, Barcelona, Spain
[4] CIBERCV, Barcelona, Spain
[5] Univ Vic Cent Catalonia UVic UCC, Dept Med, Fac Med, Vic, Spain
[6] Univ Complutense, Univ Europea, CIBERCV, Cardiol Dept,Hosp Univ Gregorio Maranon, Madrid, Spain
[7] Autonomous Univ Barcelona, Inst Catala Ciencies Cardiovasc, St Pau Hosp, Barcelona, Spain
[8] Quiron Barcelona Hosp, Barcelona, Spain
关键词
atrial fibrillation; ECG; interatrial; risk score; ADVANCED INTERATRIAL BLOCK; NEW-ONSET; ATHEROSCLEROSIS RISK; DISEASE; STROKE;
D O I
10.1111/anec.12669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Atrial fibrillation (AF) is the most common arrhythmia and has significant morbidity. A score composed of easily measured electrocardiographic variables to identify patients at risk of AF would be of great value in order to stratify patients for increased monitoring and surveillance. The purpose of this study was to develop an electrocardiographic risk score for new-onset AF. Methods: A total of 676 patients without previous AF undergoing coronary angiography were retrospectively studied. Points were allocated based on P-wave morphology in inferior leads, voltage in lead 1, and P-wave duration (MVP). Patients were divided into three risk groups and followed until development of AF or last available clinical appointment. Results: Mean age was 65 years, and 68% were male. The high- and intermediate-risk groups were more likely to develop AF than the low-risk group (odds ratio [OR] 2.4, 95% confidence interval [CI] 1.3-4.4; p = 0.006 and OR 2.1, 95% CI 1.4-3.27; p = 0.009, respectively). The high-risk group had a significantly shorter mean time to development of AF (258 weeks; 95% CI 205-310 weeks) compared to the intermediate- (278 weeks; 95% CI 252-303 weeks) and low-risk groups (322 weeks 95% CI 307-338 weeks), p = 0.005. Conclusions: A simple risk score composed of easy-to-measure electrocardiographic variables can help to predict new-onset AF. Further validation studies will be needed to assess the ability of this risk score to predict AF in other populations.
引用
收藏
页数:7
相关论文
共 30 条
  • [11] A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (from the Atherosclerosis Risk In Communities [ARIC] Study)
    Chamberlain, Alanna M.
    Agarwal, Sunil K.
    Folsom, Aaron R.
    Soliman, Elsayed Z.
    Chambless, Lloyd E.
    Crow, Richard
    Ambrose, Marietta
    Alonso, Alvaro
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (01) : 85 - 91
  • [12] Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
    Chugh, Sumeet S.
    Havmoeller, Rasmus
    Narayanan, Kumar
    Singh, David
    Rienstra, Michiel
    Benjamin, Emelia J.
    Gillum, Richard F.
    Kim, Young-Hoon
    McAnulty, John H.
    Zheng, Zhi-Jie
    Forouzanfar, Mohammad H.
    Naghavi, Mohsen
    Mensah, George A.
    Ezzati, Majid
    Murray, Christopher J. L.
    [J]. CIRCULATION, 2014, 129 (08) : 837 - 847
  • [13] The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk The TRENDS Study
    Glotzer, Taya V.
    Daoud, Emile G.
    Wyse, D. George
    Singer, Daniel E.
    Ezekowitz, Michael D.
    Hilker, Christopher
    Miller, Clayton
    Qi, Dongfeng
    Ziegler, Paul D.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (05) : 474 - 480
  • [14] Treatment of Subclinical Atrial Fibrillation Does One Plus One Always Equal Two?
    Gold, Michael R.
    [J]. CIRCULATION, 2018, 137 (03) : 217 - 218
  • [15] Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study
    Halcox, Julian P. J.
    Wareham, Kathie
    Cardew, Antonia
    Gilmore, Mark
    Barry, James P.
    Phillips, Ceri
    Gravenor, Michael B.
    [J]. CIRCULATION, 2017, 136 (19) : 1784 - 1794
  • [16] Subclinical Atrial Fibrillation and the Risk of Stroke
    Healey, Jeff S.
    Connolly, Stuart J.
    Gold, Michael R.
    Israel, Carsten W.
    Van Gelder, Isabelle C.
    Capucci, Alessandro
    Lau, C. P.
    Fain, Eric
    Yang, Sean
    Bailleul, Christophe
    Morillo, Carlos A.
    Carlson, Mark
    Themeles, Ellison
    Kaufman, Elizabeth S.
    Hohnloser, Stefan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) : 120 - 129
  • [17] January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
  • [18] Changes in Electrocardiographic P Wave Parameters after Cryoballoon Ablation and Their Association with Atrial Fibrillation Recurrence
    Kizilirmak, Filiz
    Demir, Gultekin Gunhan
    Gokdeniz, Tayyar
    Gunes, Haci Murat
    Cakal, Beytullah
    Guler, Ekrem
    Karaca, Ibrahim Oguz
    Omaygenc, Mehmet Onur
    Yilmaz, Fatih
    Olgun, Fatih Erkam
    Kilicaslan, Fethi
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2016, 21 (06) : 580 - 587
  • [19] Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population - The Suita Study -
    Kokubo, Yoshihiro
    Watanabe, Makoto
    Higashiyama, Aya
    Nakao, Yoko M.
    Kusano, Kengo
    Miyamoto, Yoshihiro
    [J]. CIRCULATION JOURNAL, 2017, 81 (11) : 1580 - +
  • [20] Interatrial block and ischemic stroke
    Lindow, Thomas
    Baranchuk, Adrian
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 7052 - 7054